SEC Form D · Amendment · filed February 7, 2019
Axon Therapies Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Paul S. Laviolette · New York, NYDirectorImran S. Eba · New York, NYDirectorSteven S. Hochberg · New York, NYDirectorHoward R. Levin · New York, NYExec · DirectorMitchell S. Bloom · New York, NYExecMark R. Gelfand · New York, NYExec · DirectorAndrew S. Elbardissi · New York, NYDirectorWadstrom Nicolai · San Francisco, CAExec · DirectorPatrick Ritschel · Durham, NCDirectorBenjamin Levy · San Francisco, CAExec · DirectorCarl J. Tippit · Cleveland, OHExecBradley M. Anderson · New York, NYDirectorDavid Pakman · New York, NYDirectorAdi Sideman · New York, NYDirectorDavid Dunn · Wilton, CTDirectorNicolai Wadstrom · San Francisco, CAExec · DirectorRagan Young · Dallas, TXExec · DirectorRobert A. Granieri · New York, NYExecChris Carvalho · Tarzana, CADirectorAndre Bliznyuk · Tarzana, CADirectorSean Madnani · Los Angeles, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗